Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01185093 · ClinicalTrials.gov registry record

St. Jude Cancer Education for Children Program: Evaluation at 4th-Grade Level

A clinical trial of Cancer, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
481
Enrollment target
1
Study location

NCT01185093 is a study of Cancer that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 481 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01185093, a study of Cancer, has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
481 participants
Enrollment target
1
Study location

Study Summary

The main objectives of the study is to * Evaluate the knowledge acquisition and retention of 4th-grade students who participate in the St. Jude Cancer Education for Children Program * To examine the relationship between outcome measures (knowledge acquisition and knowledge retention) with covariates of interest such as self-reported age and gender * To compare the knowledge scores among schools and identify the schools that may show better improvement than others and factors associated with improvement

Conditions Studied

Study Locations (1)

Tennessee

  • St . Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 481 participants
Start Date 2010-08
Est. Completion 2011-05

What the Registry Record Tells You About NCT01185093

The ClinicalTrials.gov registry entry for NCT01185093 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 481 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT01185093 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT01185093 about?

NCT01185093 is a clinical study titled "St. Jude Cancer Education for Children Program: Evaluation at 4th-Grade Level". The main objectives of the study is to * Evaluate the knowledge acquisition and retention of 4th-grade students who participate in the St. Jude Cancer Education for Children Program * To examine the relationship between outcome measures (knowledge acquisition and knowledge retention) with covariate...

What is the current status of trial NCT01185093?

This trial is currently completed. The enrollment target is 481 participants. The study started on 2010-08. Estimated completion is 2011-05.

What conditions does trial NCT01185093 study?

This clinical trial studies the following conditions: Cancer.

Who is sponsoring clinical trial NCT01185093?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01185093 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.